glp-1-based treatments approved for weight loss 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ GLP-1 Pharmacy Pricing Update (Dec

Thus, GLP-1RAs seem promising both as a preventive and symptomatic treatment for multiple sclerosis and may be useful in the treatment of other autoimmune, inflammatory, and related neurodegenerative conditions

[173] In the STEP-HFpEF trial including people with obesity and heart failure with preserved ejection fraction, weight loss was associated with improvements in heart failure symptoms and functional capacity

However, many patients prefer injecting after a small meal because it helps them avoid nausea in the minutes following the shot

With both GLP-1s and psychedelics becoming increasingly popular, it will be interesting to see what else is uncovered